On October 18, 2016, CRISPR Therapeutics AG, a Swiss-based, biopharmaceutical company focused on translating CRISPR|Cas9 gene-editing technology, and Citigroup Global Markets Inc., Piper Jaffray & Co. and Barclays Capital Inc. signed an underwriting agreement with respect to the initial public offering (IPO) and the sale and listing on the NASDAQ of up to 4,600,000 shares at a price of USD 14 each. The base offering consisted of 4,000,000 shares with an over-allotment option of up to 600,000 additional shares. The gross proceeds of the IPO amount to USD 64.4 m.

The board of directors of Hansa Medical proposes a capital raising through a directed share issue, whereby the company will receive approximately SEK 185 million. The share issue is directed to selected international specialist investors as well as Swedish institutional and strategic investors. The issue proceeds will primarily be used to finance the development process of the drug candidate IdeS up to an application for market authorization of IdeS for treatment in connection with kidney transplantation.

Cravath represented RWE AG and innogy SE in connection with innogy SE's €4.9 billion initial public offering of ordinary bearer shares, the largest IPO in Germany since 2000 and the fourth largest in the history of Germany. Formerly known as RWE International SE, innogy SE resulted from a carve-out of RWE AG's established electricity distribution and supply, retail and renewable energy divisions. The shares were listed on the Frankfurt Stock Exchange. The transaction closed on October 11, 2016.

Roschier is representing the principal shareholder Keravel S.à r.l., a company indirectly owned by CVC European Equity Fund V and CVC European Equity Tandem Fund, and Ahlsell in the initial public offering of Ahlsell's shares and listing on Nasdaq Stockholm, which is intended to take place on or around 28 October 2016. GoldmanSachs and Nordea are acting as Joint Global Coordinators and Joint Bookrunners of the offering, Carnegie, Danske Bank, Deutsche Bank, J.P. Morgan and UBS are acting as Joint Bookrunners and ABG, DNB and SEB are acting as Co-Lead Managers.

Simmons & Simmons has advised Endurance Technologies on the German law related aspects of their IPO on 19 October 2016 at the Bombay Stock Exchange and the National Stock Exchange of India.
The international team from the firm’s German and Singapore offices has advised on the listing with regards to the German operations of Endurance Technologies.

DLA Piper has advised Smart-Core Holdings Limited on its successful approximately HK230 million initial public offering on the Main Board of the Stock Exchange of Hong Kong.

Smart-Core is a leading distributor of integrated circuit and electronic components headquartered in the PRC. The company believes there will be rapid growth in its field in the future. The Hong Kong tranche was over-subscribed by 15.5 times and the international tranche was moderately over-subscribed.

Advanced Accelerator Applications S.A, a French radiopharmaceutical company specialized in the field of Molecular Nuclear Medicine, announced the public offering of 3,947,369 American Depositary Shares (ADS). The offering closed on October 12, 2016; gross proceeds of the sale of the ADSs was approximately US $172.5 million.

J.P. Morgan Securities, Jefferies LLC and Wells Fargo Securities, LLC acted as joint book-running managers for the offering. Canaccord Genuity Inc. and JMP Securities LLC acted as co-managers.

White & Case LLP has advised Jubilant Pharma Limited on its debut offering of US$300 million 4.875 percent senior unsecured notes due 2021.

Jubilant Pharma is a global integrated pharmaceuticals group offering a wide range of products and services to global pharmaceutical customers and is a wholly-owned subsidiary of Jubilant Life Sciences Limited, which is listed on the Bombay Stock Exchange and the National Stock Exchange in India.

London - Paul Hastings LLP, a leading global law firm, announced today that it advised Global Fashion Group, a portfolio company of Kinnevik and Rocket Internet, on its private placement of €330 million convertible preference shares to a group of 21 existing shareholders of the company.

As the leading online fashion retailer in the emerging markets, Global Fashion Group has a presence in 27 countries, employs more than 10,000 people worldwide and serves over 10 million customers per year.

We have advised Cambridge based PragmatIC Printing Limited on its £18 million fundraising from a syndicate of investors including new strategic investor Avery Dennison (a Fortune 500 company) and existing investors ARM and Cambridge Innovation Capital (CIC).